Davenport & Co’s 1Life Healthcare ONEM Stock Holding History

Davenport & Co’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,000	Closed	-$298K	–	1056
2021 Q2	$298K	Hold	9,000	–	–	﹤0.01%	788
2021 Q1	$352K	Sell	9,000 -3,000	-25%	-$141K	﹤0.01%	614
2020 Q4	$524K	Sell	12,000 -8,000	-40%	-$273K	0.01%	516
2020 Q3	$567K	Buy	+20,000	New	+$632K	0.01%	435

Other funds holding ONEM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

OMC

Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Davenport & Co's ONEM Position: Q3 2021 in Review

Davenport & Co sold out of 1Life Healthcare (ONEM) in Q3 2021, closing a stake of 9,000 shares — an estimated $298K sold.

Davenport & Co first reported a position in ONEM in Q3 2020 and held it in 4 quarters. The position peaked at $567K in Q3 2020. 200 funds tracked by Wall St. Rank hold ONEM as of Q3 2021.

Davenport & Co reported no remaining 1Life Healthcare position as of Q3 2021 after selling out during the quarter.
Davenport & Co sold 9,000 1Life Healthcare shares in Q3 2021, an estimated $298K.
Davenport & Co first reported a position in 1Life Healthcare in Q3 2020 and held it in 4 quarters.
Davenport & Co's 1Life Healthcare position peaked at $567K in Q3 2020.
200 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2021.

Based on Davenport & Co's 13F filing for Q3 2021, filed 14 Oct 2021.